scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0264-410X(99)00114-0 |
P698 | PubMed publication ID | 10471189 |
P2093 | author name string | K L Nichol | |
P2860 | cites work | Reduction in hospital admissions for pneumonia in non-institutionalised elderly people as a result of influenza vaccination: a case-control study in Spain | Q33704652 |
Streptococcus pneumoniae polysaccharide vaccine: age and dose responses, safety, persistence of antibody, revaccination, and simultaneous administration of pneumococcal and influenza vaccines. | Q34714546 | ||
Study of the effectiveness of influenza vaccination in the elderly in the epidemic of 1989-90 using a general practice database | Q36504369 | ||
Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials | Q40650875 | ||
Reactions following administration of influenza vaccine alone or with pneumococcal vaccine to the elderly | Q40673114 | ||
Influenza vaccine effectiveness in preventing hospitalization for pneumonia in the elderly | Q43418868 | ||
Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization | Q45260225 | ||
The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. | Q50602332 | ||
Influenza vaccine effectiveness in preventing hospitalization among the elderly during influenza type A and type B seasons | Q57109900 | ||
Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981 | Q69262720 | ||
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens | Q77302768 | ||
P921 | main subject | lung disease | Q3392853 |
P304 | page(s) | S91-3 | |
P577 | publication date | 1999-07-01 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease | |
P478 | volume | 17 Suppl 1 |
Q50462536 | Accuracy of diagnosis and classification of COPD in primary and specialist nurse-led respiratory care in Rotherham, UK: a cross-sectional study. |
Q57954001 | Additional, not additive |
Q39014333 | Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease |
Q57102084 | Benefits and effectiveness of administering pneumococcal polysaccharide vaccine with seasonal influenza vaccine: an approach for policymakers |
Q37561339 | Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis |
Q37625249 | Comparison of immunogenicity and safety of an influenza vaccine administered concomitantly with a 13-valent pneumococcal conjugate vaccine or 23-valent polysaccharide pneumococcal vaccine in the elderly. |
Q53326961 | Cost-effectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands. |
Q30309620 | Current research on respiratory viral infections: Fourth International Symposium |
Q37167208 | Does influenza vaccination of older adult Medicare beneficiaries lower treatment costs for acute and chronic respiratory disease? |
Q36665557 | Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity |
Q40079245 | Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study |
Q33719116 | Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta-analyses of observational studies |
Q30429085 | Effectiveness of vaccination with 23-valent pneumococcal polysaccharide vaccine in preventing hospitalization with laboratory confirmed influenza during the 2009-2010 and 2010-2011 seasons. |
Q73816676 | Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people: a 1-year follow-up |
Q33257893 | Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up |
Q37135413 | Factors associated with pneumococcal polysaccharide vaccination of the elderly in Spain: A cross-sectional study |
Q47750958 | Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50years of age: Results from a phase III, randomized, non-infe |
Q43177604 | Influenza and pneumococcal vaccination of the elderly in Taiwan |
Q30350930 | Influenza vaccination in the elderly: impact on hospitalisation and mortality. |
Q80394362 | Inhalative vaccination with pneumococcal polysaccharide in healthy volunteers |
Q83914964 | Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease |
Q34926870 | Pneumococcal Vaccination and Revaccination of Older Adults |
Q50580026 | Pneumococcal conjugate vaccine use in adults - Addressing an unmet medical need for non-bacteremic pneumococcal pneumonia. |
Q50672508 | Pneumococcal infection and vaccination in the elderly. |
Q47162758 | Pneumococcal vaccination and chronic respiratory diseases |
Q56524976 | Predictors of yearly influenza vaccination in hospitalized and community based patients |
Q28596774 | Prevention of COPD exacerbations: medications and other controversies |
Q91743322 | Preventive effects of pneumococcal and influenza vaccines on community-acquired pneumonia in older individuals in Japan: a case-control study |
Q35021125 | Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization |
Q93645697 | Reference list |
Q40982885 | The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program. |
Q35857208 | The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials |
Q21261529 | The impact and effectiveness of pneumococcal vaccination in Scotland for those aged 65 and over during winter 2003/2004 |
Q90435619 | Vaccination coverage with the pneumococcal and influenza vaccine among persons with chronic diseases in Shanghai, China, 2017 |
Q24201474 | Vaccines for preventing pneumococcal infection in adults |
Q24242290 | Vaccines for preventing pneumococcal infection in adults |
Q24247752 | Vaccines for preventing pneumococcal infection in adults |
Search more.